| OAE0303 | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings | Oral abstract session with live Q&A | Economic evaluation and affordability assessments |
| EPB146 | Cost-effective continuous flow synthesis of HIV second and third generation integrase inhibitor drugs: a step towards local API manufacturing in Africa | E-poster | ART in acute, first- and second-line therapies |
| EPE250 | Cost'benefit analysis of investments made in Morocco since the creation of the Global Fund (2002 - 2020) for HIV control | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
| EPE238 | Cost versus price of key drugs to treat COVID-19, HIV, HBV and HCV | E-poster | Costing of HIV, hepatitis and STI services |
| EPE245 | Cost of caregiver-assisted oral HIV screening of children in Uganda and Zambia | E-poster | Costing of HIV, hepatitis and STI services |
| EPE242 | Cost analysis of virtual outreach model to provide HIV services to key populations in India: an implementation research | E-poster | Costing of HIV, hepatitis and STI services |
| EPC193 | Correlates of adherence to daily oral HIV Pre-Exposure Prophylaxis among men that have sex with men in Nigeria | E-poster | Scale up of PrEP |
| EPC466 | Coronavirus vaccine safety in people living with HIV/AIDS | E-poster | COVID-19 prevention |
| EPC056 | Co-occurring substance use and mental health conditions and syndemics of HIV and HCV among people with opioid use disorders in a Fast-Track City in the United States | E-poster | Risk factors for acquisition, infectivity and transmission of HIV |
| EPF036 | Contribution of platforms fighting against Sexual and Gender-Based Violence (SGBV) in the prevention of HIV / AIDS and STI transmission among LGBT people in Benin | E-poster | Sexual- and/or gender-based inequalities, inequities and violence |